Samsung Bioepis hires banks for planned Nasdaq IPO -source
 

Samsung Bioepis hires banks for planned Nasdaq IPO -source
SEOUL, Aug 20 (Reuters) - South Korea's Samsung Bioepis Co Ltd, a biosimilar drug development arm of conglomerate Samsung Group, has hired four banks to manage its planned U.S. listing next year, a...http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...0Q:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...0Q:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/BI5AUcU5OYY